Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Shares of GSK PLC GSK inched down 0.55% to £15.28 Monday, on what proved to be an all-around favorable trading session for ...

New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of NeuroblastomaStudy ...

Discover the potential of nature-based real assets for institutional investors. Learn how HSBC and Pollination's Climate Asset Management is leading the way.

The company’s technology, which enables it to target viral proteins in their “prefusion” shape and skip a manufacturing step, could lead to vaccines that are more potent and easier to produce, said ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

The former head of vaccine R&D at GSK has pulled together $100 million for a London-based biotech working on respiratory ...

Tickets sold out so quickly for today’s Labour party conference “business day” that it was dubbed the corporate equivalent of ...